Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Low frequency of HLA-A*0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology.

Kanno H, Kojya S, Li T, Ohsawa M, Nakatsuka S, Miyaguchi M, Harabuchi Y, Aozasa K.

Int J Cancer. 2000 Jul 15;87(2):195-9.

2.
3.
6.
7.

Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.

Lee SP, Tierney RJ, Thomas WA, Brooks JM, Rickinson AB.

J Immunol. 1997 Apr 1;158(7):3325-34.

PMID:
9120290
8.

Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology.

Ohsawa M, Nakatsuka S, Kanno H, Miwa H, Kojya S, Harabuchi Y, Yang WI, Aozasa K.

Int J Cancer. 1999 Jun 11;81(6):865-70.

9.

HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.

Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB.

J Virol. 1993 Dec;67(12):7428-35.

10.

HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences.

Midgley RS, Bell AI, Yao QY, Croom-Carter D, Hislop AD, Whitney BM, Chan AT, Johnson PJ, Rickinson AB.

J Virol. 2003 Nov;77(21):11507-16.

11.

Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP.

Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB.

J Virol. 1988 Oct;62(10):3747-55.

12.

Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations.

Chu PG, Chang KL, Chen WG, Chen YY, Shibata D, Hayashi K, Bacchi C, Bacchi M, Weiss LM.

Am J Pathol. 1999 Sep;155(3):941-7.

13.

Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.

Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.

Int Immunol. 1992 Nov;4(11):1283-92.

PMID:
1282031
14.

Epstein-Barr virus in gastric carcinoma in Suzhou, China and Osaka, Japan: association with clinico-pathologic factors and HLA-subtype.

Qiu K, Tomita Y, Hashimoto M, Ohsawa M, Kawano K, Wu DM, Aozasa K.

Int J Cancer. 1997 Apr 10;71(2):155-8.

15.

The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan.

Tomita Y, Ohsawa M, Mishiro Y, Kubo T, Maeshiro N, Kojya S, Noda Y, Aozasa K.

Lab Invest. 1995 Aug;73(2):190-6.

PMID:
7637319
16.

Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.

Leong IT, Fernandes BJ, Mock D.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):184-93.

PMID:
11505266
17.

Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.

Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF.

Arthritis Res. 2000;2(2):154-64. Epub 2000 Feb 7.

18.

Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene.

Suzumiya J, Ohshima K, Takeshita M, Kanda M, Kawasaki C, Kimura N, Tamura K, Kikuchi M.

Leuk Lymphoma. 1999 Nov;35(5-6):567-78.

PMID:
10609794
19.
20.

Supplemental Content

Support Center